Fructooligosaccharides (FOS) are prebiotic supplements that can enhance immunological responses in the host to activate mucosal immunity, probably through regulation of gastrointestinal microflora. An area that has not been investigated, however, is the therapeutic potential of prebiotics on allergic airway diseases. The purpose of this study is to evaluate the effects of dietary supplementation with FOS on a murine model of airway inflammation induced by the house dust mite allergen Dermatophagoides farinae (Der f). Male C3H/HeN mice were intratracheally administered with Der f and were fed a diet containing 0% or 2.5% FOS ad libitum. Supplementation with FOS alleviated mite allergen-related airway inflammation characterized by eosinophilic inflammation and goblet cell hyperplasia, which was evidenced by cytological and histological examinations. In addition, the FOS-supplemented diet reduced the serum allergen-specific IgG. level as compared with a control diet in the presence ofthe mite allergen. Moreover, FOS tended to suppress the expression of IL-5 and eotaxin in the lungs, which is enhanced by mite allergen. These results suggest that dietary supplementation with FOS can prevent/improve airway inflammation induced by the mite allergen. This effect can be at least partially associated with the inhibition of allergen-specific Ig production and probably with that of IL-5 and eotaxin expression.
Allergic
asthma IS a chronic disease characterized by intermittent exacerbation of airway obstruction, airway hyperresponsiveness, and airway inflammation. Prevalence of asthma varies between 5% and 25%, and has doubled in the industrialized world over the past 20 years (I). A common explanation for this increase may be the "hygiene hypothesis," which states that the immune system's lack of microbial exposure during a critical time period early in life increases the risk of development of allergic diseases (2) . Consistent with this hypothesis, epidemiological studies implicate a positive correlation between allergic diseases and changed microbial exposure patterns in Western societies (3) .
Probiotics are live microorganisms. They improve the balance of the intestinal microflora and are linked to lower incidence rates of allergic sensitization (4) (5) . In addition, a clinical trial has demonstrated that oral administration of probiotics can be effective in the prevention and treatment of allergic diseases, especially in children (6) . It has also been experimentally suggested that these microorganisms stimulate gut-associated lymphoid tissues during the development of the immune system, resulting in a reversal of the prenatal Th2 bias into a more balanced immune response, including tolerance to ubiquitous allergens (7) .
Prebiotics are indigestible food ingredients that stimulate the growth or activity of intestinal microorganisms in the host (8) . Thus, prebiotics are probably beneficial like probiotics or live microbial food ingredients, which can prevent allergic diseases (6) (7) (8) .
Fructooligosaccharides (FOS), indigestible carbohydrates that are typical prebiotics, promote the growth of Bifidobacterium and Lactobacillus in healthy human subjects, implicating an anti-allergic property (9) (10) . In fact, FOS reportedly ameliorates food allergies mainly characterized by histological assessment of duodenal tissues in vivo (11). However, there are few reports on the anti-allergic effects of FOS outside of the gastrointestinal tract. Furthermore, it has not yet been established whether the prebiotics that regulate intestinal microflora can be a therapeutic option in the treatment of allergic asthma.
The aim of the present study is to elucidate the effects of FOS supplementation on allergic airway inflammation induced by intratracheal instillation of Dermatophagoides farinae (Der t), the major house dust mite allergen, in mice. Furthermore, we sought its underlying mechanisms.
MATERIALS AND METHODS

Animals
Male C3H/HeN mice (7 weeks old) were obtained from Japan Clea Co. (Tokyo, Japan). Animals were housed at temperatures between 23°C and 25°C with a humidity range from 55% to 70% and provided with food and water ad libitum. A 12-h light/dark cycle was maintained in the chamber room throughout the experiment. This study adhered to the National Institutes of Health guidelines for the use of experimental animals and was approved by the National Institute for Environmental Studies Animal Care and Use Committee.
Study protocol
The animals were randomized into three experimental groups. Mice were fed a diet containing 0% or 2.5% FOS (TableI) adlibitum 7 days before mite allergenadministration ( Fig. I) . A crude extract of Der f (LSL Co., Ltd., Tokyo, Japan) was dissolved in phosphate-buffered saline (PBS) solution (Nissui Pharmaceutical, Tokyo, Japan) at pH 7.4. The vehicle and Der f groups intratracheallyreceived 100 ul, ofPBS and Der f (I ug), respectively, through a polyethylene tube under anesthesia with 4% halothane (Takeda Chemical Industries, Ltd., Osaka, Japan) biweekly for 6 weeks. All mice were sacrificed using diethyl ether 24 h after the final Der f instillation.
Bronchoalveolar lavage (BAL)
The trachea was cannulated after the collection of blood. The lungs were lavaged with 1.2 ml ofsterile saline at 37°C, instilled bilaterally by syringe. The lavaged fluid was harvested by gentle aspiration. This procedure was repeated three times. Of the 3.6 ml that was instilled, the average volume retrieved was 90%; the amounts did not differ by treatment. The fluid collections were combined and cooled to 4°C. The lavage fluid was centrifuged at 300 g for 10 min, and the total cell count was determined on a fresh fluid specimen using a hemocytometer. Differential cell counts were assessed on cytological preparations. Slides were prepared using an Autosmear (Sakura Seiki Co., Tokyo, Japan) and were stained with Diff-Quik (International Reagents Co., Kobe, Japan). A total of 500 cells were counted under oil immersion microscopy (n = 8 in each group). After the BAL procedure, the lungs were removed, snap frozen in liquid nitrogen, and stored at -80°C until used for ELISA.
Histological evaluation
After the collection of blood, the lungs were fixed by intratracheal instillation of 10% neutral phosphatebuffered formalin at a pressure of 20 ern Hp. After separation of the lobes, 2-mm-thick blocks were taken for paraffin embedding. Sections 3 urn thick were stained with hematoxylin and eosin (H&E) to evaluate the degree of infiltration of polymorphonuclear or mononuclear cells around the airways. The sections were stained with periodic acid Schiff (PAS) to evaluate the degree of proliferation of goblet cells in the bronchial epithelium.
ELISA
The frozen lungs were homogenized and centrifuged as previously described (12) . The supernatants were stored at -80°C until assayed. ELISA analyses were performed to determine the protein level of interleukin (lL)-5 (Biosource International, CA) and eotaxin (Biosource International) in the lung tissue and BAL supernatants according to the manufacturer's instructions. The detection limits of these assays were 5 and 3 pglmL for IL-5 and eotaxin, respectively (n = 8-12 in each group). Der f-specific IgG) antibodies in the serum were measured by ELISA with solid-phase antigens as previously described (12) .
Real time RT-PCR
Immediately after sacrifice, lung tissue was snap frozen in liquid nitrogen and stored at -80°C. The lung tissue was homogenized in TRIzol (Invitrogen, CA). Thereafter, I ug of RNA was converted to complementary DNA using a RevertAid First Strand cDNA synthesis kit (Fermentas, MD). Aliquots of the complementary DNA were assayed by real-time quantitative PCR using an ABI PRISM 7000 sequence detection system (Applied Biosystems, CA). Primers and TaqMan probe sets were Assays-on-Demand gene expression assay mixes designed by Applied Biosystems. The relative amounts of mRNA were calculated using the comparative CT method. The quality of mRNA was normalized by the quality of~-actin mRNA in the complementary DNA sample.
Statistical analysis
Data were reported as mean ± standard deviation (SD). Multiple comparisons were calculated with one-way ANOVA, followed by Bonferroni multiple-comparison tests. P-value of less than 0.05 was considered to be significant. All statistical calculations were performed with the Winstat 3.0 EXCEL plug-in software from R. Fitch (http://www.winstat.com/.Lalmia.Cambridge.MA. USA).
RESULTS
Effects ofFOS on BAL cellularity
To estimate the effects of FOS on airway inflammation, we investigated the cellular profiles of BAL fluid (Fig. 2 ). The number of eosinophils ( Fig.  2A ) and neutrophils ( Fig. 2B ) in BAL fluid was significantly greater in the Der f group than in the vehicle group (P < 0.0 I, for eosinophils; P < 0.05, for neutrophils). In the presence of allergen challenge, dietary supplementation with FOS significantly inhibited the number of eosinophils induced by mite allergens as compared with the control diet (P < 0.05). However, the number of neutrophils inhibited did not reach statistical significance.
Effects of FOS on inflammatory cells around the airways
We next examined whether dietary supplementation with FOS could alleviate airway inflammation related to mite allergen as evidenced by histological examination (Fig.3 ). Intratracheal instillation with mite allergen led to recruitment of eosinophils and neutrophils around the airways and the proliferation of goblet cells in the airway epithelium, whereas that with the vehicle group did not. FOS apparently lessened the magnitude of airway inflammation and goblet cell hyperplasia related to mite allergen.
Effects ofFOS on cytokine and chemokine levels in the lung
To elucidate the effects of FOS on the expression of inflammatory molecules in the lungs in relation to allergy, we measured protein levels of IL-5 and eotaxin in the lung tissue and BAL supernatants 24 h after the last intratracheal instillation. The Der f group showed significant increases in IL-5 ( Fig.  4A, B) and eotaxin (Fig. 4C, D) 
Effects ofFOS on allergen-specific production ofIgs
We measured Der f-specific IgG) and IgE levels ( Fig. 5 and data not shown). These levels were significantly greater in the Der f group than in the vehicle group (P < 0.0 I). The titers were less in the Der f + FOS group than in the Der f group (P < 0.01 for IgG, and P = 0.07 for IgE, data not shown).
DISCUSSION
In the present study, dietary supplementation with FOS ameliorated mite allergen-related airway inflammation characterized by eosinophilic airway inflammation and the proliferation of goblet cells in the airway epithelium. The inhibitory effects of FOS are concomitant with a decrease in the serum allergen-specific IgG, level and probably with that in the expression ofIL-5 and eotaxin in the lungs.
In previous studies, several laboratories have demonstrated that supplementation with food the other hand, FOS tended to reduce expression of IL-5 and eotaxin in the lungs in relation to allergy. The reason why the inhibitory effects on IL-5 and eotaxin were weaker than those on lung eosinophilia and IgGI production might be due to kinet ic differences, protocol design, and/or FOS doses. Mechanisms of the suppressive impacts of FOS on Th2 humoral immun ity in the current model remain unidentified. Dietary supplementation with FOS reportedly increases IgA production (20) . Mucosal IgA plays a role in first-line clearance mechanisms of inhaled foreign matter, including allergens (21) . Furthermore, IgA can competitively block IgG-med iated activation of the compl ement. Thus, it is possible that . FOS ameliorates allergic airway inflammation through increased local levels of IgA. Addition ally, it cannot be denied that FOS promotes Ig class switching to IgA rather than IgG and IgE syntheses. In fact, another examination from our laboratory has also shown that dietary supplementation with FOS reduces allergen (ovalbumin)-specific IgGI synthesis in a murine model of allergic asthma (unpublished data). Alternatively, among the diverse probiotic strains, lactobacilli and bifidobacteria are the most promising candidates to naturally affect Treg celldevelopment (22) . Furthermore, Hosono et al. have shown that FOS induces IL-IO production ex vivo (20) , which is involved in the induction of Treg (23) . Therefore, it can be speculated that FOS modulates allergic inflammation through activation of suppressive T cell populations including Treg.
Recently, in addition, Forsythe et al. have reported that live probiotics (Lactobacillus reuteri) inhibit a murine allergic asthma model through the enhanced activity of indoleamine 2, 3-dioxygenase (6), which is an important molecule in T-cell tolerance (24) . Taken together, the above-mentioned humoral, cellular, and/or intracellular mechanisms should be candidates for research target in the future. Allergic inflammation including bronchial asthma is often associated with Th2-polarized responses. IL-5 is essential for maturation of eosinophils in the bone marrow and their release into the blood (25) . In addition, Th2 cytokines are implicated in the pathogenesis of allergic reactions via their roles in mediating IgG I and IgE production, and in the differentiation, vascular adhesion, recruitment, activation, and survival of eosinophils. Eotaxin is essential for eosinophil recruitment in allergen-related airway inflammation (26) . Actually, our previous studies have confirmed that the magnitude of allergic airway inflammation paralleled the local level of these cytokines and chemokines in vivo (12) . In the present study, FOS attenuated both IL-5 and eotaxin at the post-transcriptional and translational level, however, it did not do so to a significant extent. On the other hand, dietary supplementation with FOS conferred no influenceon the local protein expression ofIL-4 (a Th2 cytokine), IFN-y (a Thl cytokine), and keratinocyte chemoattractant (KC, a neutrophilic chemoattractant) (lL-4; undetectable, IFN-y and KC; no significant difference among experimental groups, data not shown). Thus, we should additionally seek other attributable machinery/molecules of anti-allergic/antiinflammatoryactions ofFOS, e.g. complementcascade (this pathway might be likely in view of reduced IgG I titer [ Fig. 5]) , lipid mediators, and other unexamined chamotactic factors in the future. Nonetheless, these results suggest that FOS ameliorated allergic airway inflammation partly via the suppression of local expression ofIL-5 and eotaxin.
Although most patients with asthma can be controlled by standard treatment with inhaled corticosteroids and~2-agonists, approximately 10% of patients do not respond to such a regime (27) . Thus, a new therapeutic option against this type of asthma should be sought. For instance, IL-5 blockade was expected to calm eosinophil migration/infiltration in the lungs and consequently relieve symptoms in patients with asthma. However, a humanized mAb against IL-5 (called mepolizumab) effectively depletes eosinophils from the circulatory blood and from induced sputum in mild atopic subjects with asthma, but has no effect on airway hyperresponsiveness or on the late asthmatic reaction to inhaled allergen challenge (28) and does not clinically benefit patients with steroidresistant asthma (29) . On the other hand, TNF-a antagonism may benefit these patients; however, to date, its response is heterogeneous, and there is much concern about the safety of anti-TNF-a therapy (30) . Together, other alternative therapeutic options in the presence or absence of combination with steroids are required for this refractory type of asthma; thus, prebiotics including FOS might be a candidate in future.
In conclusion, dietary supplementation with FOS ameliorates allergic airway inflammation induced by mite allergen with activated humoral immunity. This amelioration is concomitant with the suppression of Ig production and partly with the expression of IL-5 and eotaxin in the lungs. These results indicate that FOS should be considered as a supportive therapeutic option in the treatment of allergic airway diseases.
